Publications by authors named "D Krell"

Claim this Profile
M
Mixed Neuroendocrine and Non-neuroendocrine Tumor of Pancreato-Biliary Origin Treated Successfully with Peptide Receptor Radionuclide Therapy.
Kalyan Mansukhbhai Shekhda, Tu Vinh Luong, Daniel Krell, Shaunak Navalkissoor, Anna Paterson

J Gastrointest Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
Benjamin R Challoner, Andrew Woolston, David Lau, Marta Buzzetti, Caroline Fong, Daniel Krell

J Pathol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
Mairéad G McNamara, Jayne Swain, Zoe Craig, Rohini Sharma, Olusola Faluyi, Daniel Krell

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours.
Aimee R Hayes, Tu Vinh Luong, Jamie Banks, Heer Shah, Jennifer Watkins, Daniel Krell

J Neuroendocrinol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis.
Aimee R Hayes, Myles Furnace, Ruchir Shah, Caroline Rundell, Gregory Muller, Daniel Krell

Pancreas· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis